glyoxal has been researched along with glutamic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Montine, TJ; Ou, JJ; Zhang, Y | 1 |
Horiuchi, S; Kawaguchi, M; Kobayashi, M; Shibata, N | 1 |
Battu, CE; de Assis, AM; Farina, M; Gonçalves, CA; Hansen, F; Hoefel, AL; Longoni, A; Perry, ML; Rieger, DK; Schmidt, B; Sordi, F; Souza, DO | 1 |
Shiriaeva, IuK; Titov, VN | 1 |
4 other study(ies) available for glyoxal and glutamic acid
Article | Year |
---|---|
In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases.
Topics: Aging; Aldehydes; Animals; Cerebral Cortex; Corpus Striatum; Glutamic Acid; Glyoxal; Lipid Peroxidation; Microdialysis; Neurodegenerative Diseases; Rats; Rats, Sprague-Dawley | 2002 |
Glyoxal inactivates glutamate transporter-1 in cultured rat astrocytes.
Topics: Amino Acid Transport System X-AG; Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Chromatography, High Pressure Liquid; Glutamic Acid; Glyoxal; Immunoblotting; Immunohistochemistry; Lysine; Rats | 2005 |
Effects of glyoxal or methylglyoxal on the metabolism of amino acids, lactate, glucose and acetate in the cerebral cortex of young and adult rats.
Topics: Acetates; Aging; Amino Acids; Animals; Carbon Dioxide; Central Nervous System Agents; Cerebral Cortex; Female; Glucose; Glutamic Acid; Glutamine; Glycine; Glyoxal; Lactic Acid; Lipid Metabolism; Male; Oxidation-Reduction; Protein Biosynthesis; Pyruvaldehyde; Rats; Rats, Wistar | 2010 |
[The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
Topics: Arteriolosclerosis; Atherosclerosis; Diabetes Mellitus; Diabetic Angiopathies; Glucose; Glutamic Acid; Glycation End Products, Advanced; Glycosylation; Glyoxal; Humans; Metabolic Networks and Pathways; Oxidation-Reduction; Proteolysis; Pyruvaldehyde; Vascular Diseases | 2011 |